55 results
424B7
RYTM
Rhythm Pharmaceuticals, Inc.
10 Jul 24
Prospectus with selling stockholder info
4:05pm
or concessions allowed to such broker-dealer(s), where applicable, (v) that such broker-dealer(s) did not conduct any investigation to verify
8-K
EX-10.1
RYTM
Rhythm Pharmaceuticals, Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
.
(h) Litigation. There is no action, suit, proceeding or investigation pending or, to the Knowledge of the Company, threatened (including “cease … Adverse Effect; (iv) have not received written notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other
8-K
EX-1.1
8jm9ozbcp6ozzsyx411
15 Sep 22
Other Events
4:02pm
S-3
EX-4.3
xhy8qenwb 10fh
2 Nov 21
Shelf registration
5:21pm
S-3
EX-1.2
099wxiw wj33
2 Nov 21
Shelf registration
5:21pm